Business Standard

Emcure Pharmaceuticals Share Price

Know More
BSENSE

1,357.15 8.20 (0.61%)

10:07 AM, 13-Dec-2024

1,355.20 9.70 (0.72%)

09:54 AM, 13-Dec-2024

BSE : 544210

NSE : EMCURE

Sector : Health care

ISIN Code : INE168P01015

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 13-Dec-2024 | 10:07 AM IST

Market Cap (₹ Cr)

25,708

Traded Value (₹ Cr)

0.04

Volume (Shares)

317

Face Value (₹)

10

52-Week High (₹)

1,577.50

52-Week High Date

18-Sep-2024

52-Week Low (₹)

1,226.50

52-Week Low Date

13-Aug-2024

All Time High (₹)

1,577.50

All Time High Date

18-Sep-2024

All Time Low (₹)

1,226.50

All Time Low Date

13-Aug-2024

Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Limited was originally incorporated as `Emcure Pharmaceuticals Private Limited' as a Private Company pursuant to a Certificate of Incorporation dated April 16 1981 issued by Registrar of Companies Maharashtra at Bombay. Subsequently Company was converted into a Public Company and the name of Company was changed to `Emcure Pharmaceuticals Limited' through a fresh Certificate of Incorporation issued by the RoC Maharashtra in Pune on September 18 2001.Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing manufacturing and globally marketing a broadrange of pharmaceutical products across several major therapeutic areas. They are a research and devel...
Read More

Emcure Pharma News

This pharma stock listed in July has rallied 10% in trade; Check details

3 min read

Emcure Pharma shares climb 6% after strong growth in Q2FY25 results

2 min read

Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?

3 min read

Emcure Pharma listing: Stock makes solid debut on NSE, BSE with 31% premium

3 min read

Trading guide July 10: Nifty poised to open flat; Emcure, Bansal to list

6 min read
More

Emcure Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

25,672

EPS - TTM (₹) [C]

30.30

P/E Ratio (X) [C]

44.73

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) 0.21
Book Value Share (₹) [C]217.42
P/B Ratio (₹) [C]6.23

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Nippon India Multi Cap Fund (G) 136.50 10,00,000 0.35
Nippon India Multi Cap Fund (IDCW) 136.50 10,00,000 0.35
Nippon India Multi Cap Fund (B) 136.50 10,00,000 0.35
Nippon India Multi Cap Fund - Direct (G) 136.50 10,00,000 0.35
Nippon India Multi Cap Fund - Direct (B) 136.50 10,00,000 0.35
Nippon India Multi Cap Fund - Direct (IDCW) 136.50 10,00,000 0.35
Aditya Birla SL ELSS Tax Saver Fund (IDCW) 57.08 4,18,179 0.36
Aditya Birla SL ELSS Tax Saver Fund (G) 57.08 4,18,179 0.36
Aditya Birla SL ELSS Tax Saver Fund - Direct (IDCW) 57.08 4,18,179 0.36
Aditya Birla SL ELSS Tax Saver Fund - Direct (G) 57.08 4,18,179 0.36

Load more

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

1,343.00

1,358.75

Week Low/High (₹)

1,336.10

1,391.00

Month Low/High (₹)

1,278.00

1,443.00

Year Low/High (₹)

1,225.00

1,580.00

All time Low/High (₹)

1,226.50

1,580.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-1.18%-1.00%-1.16-1.23%
1 Month1.60%1.63%3.953.46%
3 Month-4.61%-4.72%-2.57-3.88%
6 Month%%5.144.16%
1 Year%%16.0616.47%
3 Year%%38.5740.33%

Company Info

Company Information

Whole Time Director : MUKUND KESHAO GURJAR

Whole Time Director : SUNIL RAJNIKANT MEHTA

Managing Director & CEO : SATISH RAMANLAL MEHTA

Chairman & Independent Directo : Berjis M Desai

Whole Time Director : NAMITA VIKAS THAPAR

Independent Director : P S Jayakumar

Independent Director : Vijay Gokhale

Independent Director : Vidya Rajiv Yeravdekar

Non Executive Director : Samonnoi Banerjee

Independent Director : Shailesh Ayyangar

Whole-time Director : SAMIT SATISH MEHTA

Company Sec. & Compli. Officer : CHETAN RAJENDRA SHARMA

Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000

Email:investors@emcure.com

URL:http://www.emcure.com

FAQs about Emcure Pharmaceuticals Ltd

1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 1,357.15 at 10:07 AM IST on 13th Dec 2024. Emcure Pharmaceuticals Ltd share price was up by 0.61% over the previous closing price of Rs 1,348.95. Emcure Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Emcure Pharmaceuticals Ltd share price moved up by 1.60% on BSE
  • Last 3 Months: Emcure Pharmaceuticals Ltd share price moved down by 4.61% on BSE
  • Last 12 Months: Emcure Pharmaceuticals Ltd share price moved up by % on BSE
  • Last 3 Years: Emcure Pharmaceuticals Ltd price moved up by % on BSE


2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 44.73
  • Price to book value ratio is 6.23
  • Dividend yield of 0.21
  • The EPS (trailing 12 months) of the Emcure Pharmaceuticals Ltd stock is Rs 30.30


3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 25,708 crore.


4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,577.50 and 52-week low share price is Rs 1,226.50.


5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 86.92 crore on a total income of Rs 1,159.56 crore for the quarter ended 2024. For the year ended Sep 2024, Emcure Pharmaceuticals Ltd had posted a profit of Rs 201.55 crore on a total income of Rs 2,037.64 crore.


6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Gland Pharma, J B Chemicals &, Natco Pharma, Emcure Pharma, Pfizer, Concord Biotech, Wockhardt.


7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Emcure Pharmaceuticals Ltd has gone down to 78.08 per cent as of Sep 2024 from per cent as of .